![]() |
| Karen Hiser |
For example, a few weeks ago I participated in a chat on Twitter with Chris Thoen, managing director of Proctor & Gamble’s Global Open Innovation Office. Hosted by open innovation strategic advisor Stefan Lindegaard, the chat covered topics ranging from how to select an ideal partner to lessons learned from Thoen’s experiences at P&G.
I was pleased to hear about P&G’s broad definition for open innovation—which closely matches Fuentek’s definition of Symbiotic Innovation—encompassing traditional out-licensing, R&D partnerships, and in-licensing simultaneously. As P&G’s Thoen put it during the chat, “out-licensing is [a] way to build healthy partners.” (Check out Laura’s post on other ways that out-licensing (spin-out) facilitates partnership development (spin-in).)
![]() |
| Click on image to view larger |
P&G’s embracing of open innovation clearly is helping solidify its dominance as a consumer products leader. And at Fuentek, we’ve seen time and time again—through years of experience and success after success—how employing Symbiotic Innovation can help organizations meet their R&D needs and license their technologies to meet the needs of others.
Are you practicing Symbiotic Innovation? We’d love to hear about it. And you can learn more about Fuentek’s Symbiotic Innovation services here.
–By Karen Hiser


No comments:
Post a Comment